Need professional-grade analysis? Visit stockanalysis.com
$520.54M
3.72
1,850
6.81%
Embecta Corp (EMBC) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at $9.21, up 0.88% from the previous close.
Over the past year, EMBC has traded between a low of $8.57 and a high of $15.11. The stock has lost 18.7% over this period. It is currently 39.1% below its 52-week high.
Embecta Corp has a market capitalization of $520.54M, with a price-to-earnings ratio of 3.72 and a dividend yield of 6.81%.
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Side-by-side comparison against top Healthcare peers.